account_id none on file
legal_name Kiora Pharmaceuticals Inc
ticker KPRX
cik 1372514
domain kiorapharma.com
linkedin_company_url https://www.linkedin.com/company/17981468/admin/
entry_point_account_id none on file
name Kiora Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
hq Encinitas, CA, United States
sector index/company/sector/health-care/
calls 0 filings 6 executives 5 family 0
why_nownone on file
callsnone on file
filings
These benefits can include interest and principal payments, earnings, cost savings, tax deductions, or proceeds from its disposition.
filing / Aug 7, 2026 / receipt
In May 2022, the Company entered into a 12-month lease for office space in Adelaide, Australia (the "Adelaide Lease") which expired in May 2023.
filing / Aug 7, 2026 / receipt
The Company also entered into a lease for office space in Vienna, Austria (the "Vienna Lease"). The Vienna Lease commenced on October 15, 2023 with a term of 5 years through October 14, 2028.
filing / Aug 7, 2026 / receipt
These benefits can include interest and principal payments, earnings, cost savings, tax deductions, or proceeds from its disposition.
filing / May 8, 2026 / receipt
The Company also entered into a lease for 910 square feet of office space in Vienna, Austria (the "Vienna Lease"). The Vienna Lease commenced on October 15, 2023 with a term of 5 years through October 14, 2028.
filing / May 8, 2026 / receipt
In May 2022, the Company entered into a 12-month lease for office space in Adelaide, Australia (the "Adelaide Lease") which expired in May 2023.
filing / May 8, 2026 / receipt
executives
| Eric J. Daniels | Chief Development Officer | - | receipt |
| Melissa Tosca | Executive Vice President | receipt | |
| Ryan R. Brenneman | Chief Financial Officer | - | receipt |
| Sarah M. Romano | Interim Chief Financial Officer | - | receipt |
| Susan L. Drexler | Interim Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-06 | earnings call | scheduled | ir |
changes
| 2023-09-21 | Chairman, departed | sec_8k |
| 2022-09-16 | Executive Vice President, appointed | sec_8k |
| 2022-04-26 | Interim Chief Financial Officer, appointed | sec_8k |
| 2022-02-28 | Chief Financial Officer, departed | sec_8k |
| 2021-10-26 | Chief Development Officer, appointed | sec_8k |
| 2017-02-06 | Interim Chief Financial Officer, appointed | sec_8k |
| 2016-04-29 | Chief Financial Officer, appointed | sec_8k |
mcp_package_hint
slug kiora-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$